Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation
Open Access
- 10 January 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 121 (2), 360-368
- https://doi.org/10.1182/blood-2012-01-404889
Abstract
Increased microvessel density contributes to abnormal BM and spleen microenvironment in myelofibrosis (MF). Taking advantage of the JAK2V617F mutation as a marker of malignancy, in the present study, we investigated whether splenic endothelial cells (ECs) obtained from capillaries by laser microdissection or from fresh spleen tissue by cell culture or cell sorting harbored such mutation in patients bearing the mutation in their granulocytes and undergoing splenectomy for therapeutical reasons. To extend the analysis to the ECs of large vessels, endothelial tissue from the splenic vein was also studied. We found JAK2V617F+ ECs in 12 of 18 patients also bearing the mutation in their granulocytes. In 3 patients, the mutation was found in at least 2 different EC samples obtained by laser microdissection, cell culture, or cell sorting. The mutation was detected in the splenic vein ECs of 1 of 6 patients investigated. In conclusion, we provide evidence that some ECs from the spleen and splenic veins of patients with MF bear the JAK2V617F mutation. We suggest that splenic ECs are involved in the process of malignant transformation in MF.Keywords
This publication has 35 references indexed in Scilit:
- New mutations and pathogenesis of myeloproliferative neoplasmsBlood, 2011
- Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasmsBlood, 2011
- Transdifferentiation of glioblastoma cells into vascular endothelial cellsProceedings of the National Academy of Sciences of the United States of America, 2011
- High Frequency of Endothelial Colony Forming Cells Marks a Non-Active Myeloproliferative Neoplasm with High Risk of Splanchnic Vein ThrombosisPLOS ONE, 2010
- Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumorsBlood, 2010
- A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicryBrain, 2010
- The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndromeBlood, 2009
- The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 casesBlood, 2008
- Tumor Origin of Endothelial Cells in Human NeuroblastomaJournal of Clinical Oncology, 2007
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996